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Background: Ubiquitin modification of histones regulates gene expression.
Results: USP42 targets histone H2B at promoters, leading to decreased ubiquitylation. This correlates with the regulation of
transcription driven by a number of transcription factors.
Conclusion: USP42 contributes to the modulation of transcription.
Significance:The identification of histoneH2B as a target for USP42 extends our understanding of the factors that can regulate
gene expression.
Ubiquitin-specific peptidase 42 (USP42) is a deubiquitylating
enzyme that can target p53 and contribute to the stabilization of
p53 in response to stress. We now show that USP42 can also
regulate transcription independently of p53. USP42 co-local-
izedwithRNApolymerase II (RNAPol II) in nuclear foci, bound
to histone H2B, and deubiquitylated H2B. Depletion of USP42
increased H2B ubiquitylation at a model promoter and
decreased both basal and induced transcription from a number
of promoters. These results are consistent with a role for USP42
in regulating transcription by deubiquitylating histones.
Post-translational modifications are critical mechanisms
through which protein activity is regulated. Conjugation of
ubiquitin can control the function of target proteins inmultiple
ways, including degradation, subcellular localization, and activ-
ity (1, 2). The consequences of ubiquitylation vary depending
on the type and length of the ubiquitin chain, and many pro-
teins are controlled through ubiquitylation (1–4). The process
itself is highly regulated with a cascade involving ubiquitin-
activating, ubiquitin-conjugating, and ubiquitin-ligating
enzymes promoting the conjugation of ubiquitin to selected
target proteins. This process can be reversed by the activity of
deubiquitylating enzymes (DUBs)4 that remove ubiquitin (5, 6).
p53 is a potent tumor suppressor protein that is primarily
regulated at the level of protein stability (7). A number of ubiq-
uitin ligases that target p53 for polyubiquitylation and degrada-
tion have been described, including MDM2 (8, 9), Chip (10),
Pirh2 (11), and ARF-BP1 (12). MDM2 itself is also regulated by
ubiquitylation and degradation, and several DUBs, including
USP7 (13), USP2a (14), and USP15 (15), have been shown to
promote p53 degradation by deubiquitylating and stabilizing
MDM2. p53 is also the direct target of a number of DUBs,
including USP10 (16), USP29 (17), USP42 (18), and Otubain1
(19). After DNA damage and its phosphorylation by ATM,
USP10 localizes to the nucleus to stabilize p53. USP42 was
shown to play a role in accelerating the stabilization of p53 in
response to genotoxic stress. However, it was clear from these
studies that lack of USP42 delayed but did not prevent the full
stabilization of p53 protein (18).
As with other protein modification systems, the potential
number of target proteins exceeds the number of DUBs
(around 100 in humans (20)), indicating that each DUB is likely
to target many different proteins. In our continued analysis of
USP42 function, we have identified monoubiquitylated histone
H2B as a target for deubiquitylation by USP42. The dynamic
interchange and balance between ubiquitylation and deubiqui-
tylation of histones is critical for the regulation of transcription
(21–26), and our data suggest that USP42 may be an important
component of this fundamental level of control of transcrip-
tional activity.
EXPERIMENTAL PROCEDURES
Tissue Culture—Cells were cultured in DMEM supple-
mented with glutamine and 10% FCS.
Plasmids—GFP-FLAG-USP42 and USP42 C120A have been
described before (18). All deletion constructs were derived by
PCR-based deletion using KOD Hot Start polymerase (Merck
Millipore, 71842).
Transfection—Cells were transfected with the indicated plas-
mids (Genejuice,MerckMillipore, 70967) or siRNA (Hiperfect,
Qiagen, 301705) as described before (18).
Western Blotting—Gels were transferred to a nitrocellulose
membrane using a Mighty Small chamber from Hoefer. Blots
were blocked in 5% milk TBS-Tween for at least 20 min and
incubated with the appropriate antibodies overnight at 4 °C on
a shaker. After three 5-min washes with TBS-Tween, the blots
were incubated with the appropriate LI-COR Biosciences sec-
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ondary antibody (in 5% milk TBS-Tween in a 1:10,000–20,000
dilution) followed by LI-CORBiosciencesOdyssey detection (K
set to 1). Antibodies used were: USP42 (Atlas, HPA006752),
GFP (Abcam, ab6556; Roche Applied Science, 11814460001),
H2B (Cell Signaling Technology, 2934), RNA Pol II (Santa
Cruz, SC-65884), actin (Santa Cruz, SC-1616), tubulin (Santa
Cruz, SC-8035), Ubi-H2B (Cell Signaling Technology, 5546),
H2A (Cell Signaling Technology, 3636), and Ubi-H2A (Milli-
pore, 05-678; Cell Signaling Technology, 8240). Western blots
were quantified using the LI-COR Biosciences Image Studio
software V 2.1.10 and plotted using PRISM software from
GraphPad.
Immunoprecipitation—Cells were washed once with PBS,
scraped in 1 ml of PBS into a 1.5-ml Eppendorf tube, and cen-
trifuged for 5 min at 3000 rpm at 4 °C in a refrigerated Eppen-
dorf microcentrifuge. Cells were subsequently lysed in lysis
buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 0.25% deoxy-
cholic acid, 1% Nonidet P-40, protease inhibitor mixture
(Roche Applied Science, 04693159001)) and sonicated in a Bio-
ruptor (20 s at lowest setting) to lyse the chromatin. Magnetic
protein G beads (Invitrogen, 10004D) or Dynabeads Rat anti-
Mouse IgM (Invitrogen, 11039D) were washed three times in
lysis buffer and blocked in lysis buffer plus 5% BSA for 1 h.
Beads, antibody, and lysates were mixed; the volume was
topped up to 700 l with lysis buffer and samples were rotated
overnight at 4 °C, washed three times in lysis buffer and boiled
in 1 SDS reducing loading buffer for elution.
Immunofluorescence—Confocal immunofluorescence was
performed as described previously (27). In brief, cells were cul-
tured on coverslips at approximately 70% confluence. At har-
vesting, cells were washed three times in PBS, fixed in 4% para-
formaldehyde for 15 min, and stained with DAPI solution. For
colocalization ofUSP42 andDNA-boundRNAPol II, cells were
washed in CSK buffer (0.3 M sucrose, 10 mM PIPES, 3 mM
MgCl2, 1 mM EGTA, 0.5% Triton X-100) prior to fixation to
remove unbound soluble proteins.
FACS Analysis—A U2OS clone stably expressing CMV
Cherry and doxycycline-inducible GFP was established by
puromycin selection over 3 months followed by colony picking
and characterization. After transfection with plasmids or
siRNA, cells were induced with doxycycline or solvent control
as described in the text. Cells were then harvested by trypsiniza-
tion and resuspended in 1% FCS in PBS-Tween followed by
immediate FACS analysis (BD FACSAria). FlowJo was used to
determine the median fluorescence.
Chromatin Immunoprecipitation—Chromatin immunopre-
cipitation was performed as described before (18).
In Vitro Deubiquitylation Assays—USP42 constructs were
expressed in HEK293T cells, lysed in radioimmune precipita-
tion assay buffer, and purified by precipitation using GFP-
trap_M matrix (CromoTek, gtm-20). Histones were purified
from HeLa cells using an acid extraction protocol (Abcam). In
brief, nuclear extracts were incubated with 0.2 N HCl overnight
followed by centrifugation, aliquoting, freezing in liquid N2,
and storage at 80 °C. Assays: HeLa histones were thawed,
rebuffered with NaOH, and diluted in 50 mM Tris, pH 8 to a
volume of 80 l. Aliquots were added to purified USP42 on
GFP-trap_M matrix and incubated at room temperature, and
10-l samples were taken at the indicated time points, mixed
1:1 in 2 SDS loading buffer, and boiled for 5 min to stop the
deubiquitylation reaction.
Fractionation—Cells were treated as described previously
(31). In brief, after fractionation into nuclear and cytoplasmic
fractions, the nuclear fraction was further separated by incuba-
tion in lysis buffer (described above) and centrifuged into DNA
bound (pellet) and nuclear soluble fractions.
RESULTS ANDDISCUSSION
Our previous work showed that USP42 can target p53 for
deubiquitylation, with depletion of USP42 resulting in delays in
stabilization of p53 and recruitment of p53 to target gene pro-
moters (18). However, these studies also showed that USP42
loss did not impact the fully activated levels of p53, which were
stabilized to a similar extent irrespective of USP42 expression
within 16 h of genotoxic or ribosomal stress. In these studies,
the low dose of actinomycin D used has been shown to induce
ribosomal stress and specifically activate p53 rather than more
generally interfere with transcription (28). In agreement with
these published data, we have found that depletion of USP42
does not impact recruitment of p53 to the p21(CDKN1A) pro-
moter when examined at a 16-h time point after induction of a
p53 response with low dose actinomycin D (Fig. 1A). Interest-
ingly, USP42 was also recruited to the p21 locus after actino-
mycin D treatment, but importantly the binding of USP42 was
at sites distinct from those bound by p53. AlthoughChIP assays
detected p53 on its well characterized binding site in the p21
distal promoter (29), USP42 was detected further downstream
at the transcription start site of the p21 gene (Fig. 1B). To deter-
mine whether USP42 recruitment depends on the activation of
p21 transcription by p53, we repeated the experiment in con-
trol and p53 knockdown cells (Fig. 1C). Although USP42
recruitment to the start site and the first intron was clearly
increased following lowdose actinomycinD treatment, thiswas
at least partially dependent on p53 because a knockdown of p53
caused a reduction ofUSP42 recruitment. Taken together these
data suggest thatUSP42 participates in transcription regulation
through a mechanism that is dependent on p53 but likely to be
independent of direct binding to p53. An overview of the ChIP
primers is shown in Fig. 1G.
To further understand this role of USP42, we examined its
localization in the cell. Fractionation studies indicated that
USP42 was associated with the insoluble chromatin fraction,
and this localization was independent of DUB activity because
it was also seen with the catalytically inactive USP42 mutant
C120A (Fig. 1D). Immunofluorescence analysis of endogenous
proteins showed that USP42 was present in nuclear foci that
co-localized with DNA-bound RNA Pol II using antibodies to
detect both total and activated (phosphorylated) RNA Pol II
(Fig. 1E), and endogenousUSP42 andRNAPol IIwere shown to
co-immunoprecipitate (Fig. 1F). This was of particular interest
because a proteomic analysis of USP42-binding proteins had
shown association of USP42 with histone H2B and other com-
ponents of the transcriptional machinery (not shown).
To confirm this interaction, we immunoprecipitated
endogenous USP42 from cells and were able to detect a spe-
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cific interaction with histone H2B (Fig. 2A). Expression of
USP42 mutants targeting the linker domain and the C-ter-
minal lysine-rich domain (Fig. 2B) showed that although the
DUB-inactive USP42 C120A mutant retained the ability to
bind histone H2B, this interaction was reduced with theKK
mutant and lost with the linker mutant (Fig. 2C). Immuno-
fluorescence studies confirmed that both wild type and
C120A USP42 proteins retained localization within nuclear
foci previously associated with DNA-bound RNA Pol II,
whereas the KK mutant showed a diffuse nuclear localiza-
tion, and the linker mutant was relocalized to subnuclear
structures likely to be nucleoli (Fig. 2D).
FIGURE 1. USP42 binds to the start region of transcriptionally active p21 promoter and localizes in nuclear foci. A, chromatin immunoprecipitation
showing the recruitment of p53 to its binding site and not to the start and elongation region of the p21 gene upon its induction. Error bars represent the S.D.
of three independent replicas.B, chromatin immunoprecipitation showing the recruitmentofUSP42 to the start andelongation regionof thep21geneandnot
to thep53binding site. Error bars represent the S.D. of three independent replicas.C, chromatin immunoprecipitation showing the recruitment ofUSP42 to the
p21 start and elongation region in control and shp53 cells with andwithout actinomycinD (ActD) treatment. Error bars represent the S.D. of three independent
replicas. D, fractionation of U2OS cells overexpressing USP42 WT and C120A. USP42 associates with the chromatin independently of its catalytic activity. E,
confocal immunofluorescence visualizing the localization of endogenous USP42 and DNA-bound RNA Pol II (total and activated) after extracting soluble
proteins inU2OS cells. F, endogenous coimmunoprecipitation of USP42 andRNAPol II. U2OS cellswere lysed, and the proteinswere immunoprecipitatedwith
the indicated antibodies.G, map of the p21 locus with primer amplicons. Positions are relative to the start site. CTL, control; cyto, cytoplasmic; nuc, nuclear; Pol
II, RNA Pol II; Scr, scrambled.
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The binding of USP42 to histone H2B suggested that USP42
may target histones for deubiquitylation. Indeed, in vitro anal-
ysis showed that USP42 is able to efficiently deubiquitylate his-
tone H2B (Fig. 2, E and F). This activity was dependent on the
DUB activity of USP42 because the C120A mutant was unable
to deubiquitylate histone H2B in this assay (Fig. 2, E and F).
Interestingly, the KK mutant and linker mutants retained
the ability to deubiquitylate histone H2B in this in vitro assay,
suggesting that the failure of these mutants to effectively target
histone H2B in cells is a reflection of their inappropriate local-
ization rather than a loss of DUB activity. In the in vitro assay,
USP42 showed a similar ability to deubiquitylate histones H2A
and H2B (Fig. 2G). However, in cells, the ubiquitination of his-
tone H2A was not affected by USP42 depletion, whereas the
overall level of ubiquitylated H2B was modestly but consis-
tently increased (Fig. 2H). These results indicate that the ability
of USP42 to target proteins is regulated by factors in addition
to DUB activity such as the control of appropriate cellular
localization.
Because histoneH2Bubiquitylation and deubiquitylation are
important for transcriptional regulation (22), we postulated
that USP42 may be able to influence transcription efficiency
from promoters beyond those regulated by p53. To analyze an
effect of USP42 on more general transcription, we turned to a
model system in which fluorescent reporter proteins (Cherry
and GFP) are stably integrated in the genome and expressed
from constitutive (CMV, Cherry) or inducible (doxycycline,
GFP) promoters. This system makes it possible to directly
manipulate the induction of GFP without having to take other
regulatory processes into account. In addition, this system
allows us to normalize expression of the reporter protein on a
per cell basis rather than to a housekeeping factor that itself
may be regulated byUSP42. siRNAdepletion ofUSP42 resulted
in an overall reduction of CMV-driven Cherry expression
detected directly by FACS (Fig. 3,A andB). Interestingly, deple-
tion of USP42 also slightly reduced the basal expression
of doxycycline-driven GFP and substantially decreased the
induced levels of GFP expression following doxycycline treat-
ment of the cells (Fig. 3,C andD). The inhibition ofGFP expres-
sion on a basal level and postinduction with doxycycline could
be observed at bothmRNA (Fig. 3E) and protein levels (Fig. 3F),
confirming that modulation of USP42 expression regulates the
transcription of both constitutive and inducible promoters.
To determine whether the knockdown of USP42 also affects
the transcription of endogenous loci, we analyzed the effect of
USP42 knockdown on the transcription of p53 target genes
upon its induction with actinomycin D and Nutlin. p21 was
chosen because we have demonstrated that USP42 is recruited
to the p21 transcription start site after p53 induction (Fig. 1B),
and induction of p53 itself relies mainly on stabilization of
protein levels rather than induction of p53 transcription. To
extend the study, we also examined a further 19 p53-induc-
ible genes (Fig. 3G). As expected, p53 target genes were
induced upon both Nutlin and actinomycin D treatment,
resulting in increased mRNA expression (Fig. 3G). USP42
depletion decreased the transcription of most of these target
genes, although some (CASP1, PUMA, BAX, PIDD, and
WIP1) were not affected (Fig. 3G). We have shown previ-
ously that USP42 depletion retards the stabilization of p53.
Importantly, therefore, at this time point (16 h), p53 protein
was fully stabilized regardless of USP42 status (Fig. 3H). Nev-
ertheless, expression of target proteins p21 and MDM2
remained at lower levels, correlating with the lower mRNA
expression (Fig. 3G).
To assess how the knockdown of USP42 induces a change
in transcription froman endogenous promoter, we investigated
the influence of USP42 reduction on the p21 promoter.
Although p53 was recruited to the p53 response element fol-
lowing actinomycin D treatment (Fig. 1A), there was no change
in the level of H2B ubiquitylation around this site, and the
knockdown of USP42 did not lead to an increase of H2B ubiq-
uitylation here (Fig. 4A). By contrast, increased H2B ubiquity-
lation was detected at the transcriptional start site and first
intron of the p21 gene following actinomycin D treatment
(whereUSP42was bound; Fig. 1B). Reduction ofUSP42 expres-
sion by siRNA led to a further increase of H2B ubiquitylation
(Fig. 4A) but did not alter overall deposition of histone H2B
(Fig. 4C). Interestingly, USP42 did not affect H2A ubiquityla-
tion (Fig. 4B) or deposition (Fig. 4D). These results suggest that
USP42 can specifically modulate the levels of H2B ubiquityla-
tion in the first nucleosomes of the p21 coding sequences in
response to p53 activation. To determine the outcome of
USP42 knockdown on p21 transcription, we analyzed p21
mRNA levels at several time points after induction with and
without USP42 depletion (Fig. 4E). As we had demonstrated
before, USP42 knockdown lowers p21 transcription at the early
time points of p53 induction as a reflection of the reduced levels
of p53 (18). However, at time points where p53 levels (Fig. 3H)
and p53 recruitment to the p21 promoter (Fig. 1A) have
become equal, the levels of p21mRNAexpression remain lower
in USP42-depleted cells (Fig. 4E). To determine whether the
increased levels of Ubi-H2B observed at the p21 locus after
USP42 depletion affected RNA Pol II migration, we analyzed
RNA Pol II distribution in a ChIP experiment. Interestingly, we
FIGURE 2. The linker and lysine-rich domain of USP42 are necessary for appropriate localization of USP42 and interaction of histone H2B. A, endog-
enous coimmunoprecipitation showing specific interaction of USP42 and H2B. B, schematic representation of the USP42 overexpression mutants used in
subsequent experiments. C, immunoprecipitation of GFP-USP42 mutants to determine their interaction with H2B. Although the catalytic activity of USP42 is
not required tobindH2B, deletionof the linker domain causes loss ofH2Bassociation, anddeletionof the lysine-richdomain leads to a reductionof interaction.
D, confocal immunofluorescence visualizing the localization of GFP-USP42 wild type and mutant proteins. Although the catalytic activity of USP42 does not
alter the localization of USP42, deletion of the linker domain causes accumulation in the nucleoli, and deletion of the lysine-rich domain leads to a diffuse
nuclear localization. E, in vitrodeubiquitylation assay of Ubi-H2BbyUSP42.Wild typeUSP42 efficiently deubiquitylates Ubi-H2B. Disruption of theDUBdomain
rendersUSP42 inactive towardUbi-H2B.KKmutant andlinkermutants,whichbothharbor an intactDUBdomain, retain theability todeubiquitylatehistone
H2B. F, quantification of E. Ubi-H2B Western blots shown in E were quantified using the LI-COR Biosciences Odyssey. G, In vitro deubiquitylation assay of
Ubi-H2B and Ubi-H2A by USP42.H, depletion of USP42 leads to an increase in H2B ubiquitylation and does not alter H2A ubiquitination. LI-COR quantification
showing levels of H2B and H2A ubiquitylation (Ubi-Histone) normalized to unmodified histone with and without USP42 knockdown. Error bars represent the
S.D. of three independent replicas. IP, immunoprecipitation; CTL, control.
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could observe increased levels of RNA Pol II association at the
proximal region of the p21 transcriptional start site upon
USP42 knockdown, whereas USP42-depleted cells showed a
reduction in RNA Pol II levels in the more distal part of the p21
gene (Fig. 4F). Taken together these results are consistent with
amodel where stalling of RNA Pol II at the transcriptional start
site and inhibition of transcriptional progression are caused by
an inability to deubiquitinate H2B.
To extend our studies beyond p53, we investigated how
USP42 reduction alters the induction of E2F1 target genes in an
inducible system. As observed with the induction of GFP (Fig.
3) and p53 (Figs. 3 and 4), depletion of USP42 reduced the
mRNA expression of most of the E2F1-induced target genes
examined (Fig. 5A). Again, we found three examples of genes
thatwere not significantly affected byUSP42 depletion (TAp73,
FOXM1, and CCNE1), indicating that the requirement for
USP42 to promote transcription is not universal.
Taken together the results support a model whereby USP42
directly influences transcription by deubiquitylating histone
H2B at transcriptional start sites (Fig. 5B). As demonstrated in
FIGURE 3.USP42 is necessary for efficient transcription of reporter genes. A–D, FACS analyses of a U2OS clone stably expressing Cherry and doxycycline-
inducible GFP. USP42 knockdown leads to a reduction of Cherry signal (A and B) and to a drop of GFP signal in both the basal and induced transcription (C and
D). Error bars represent the S.D. of three technical replicas. E, quantitative RT-PCR analysis of GFP expression. The U2OS clone was induced with doxycycline
(Dox)with andwithoutUSP42knockdown, and theGFPmRNAwasquantifiedby real timePCR.GFPmRNA levelsdroppedafterUSP42knockdownboth inbasal
conditions and after GFP induction by doxycycline. Error bars represent the S.E. of three technical replicas. F, Western blot for GFP and USP42 visualizing the
reduction of USP42 protein after knockdown and the resulting drop in GFP protein levels in basal and doxycycline-induced conditions. G, mRNA expression
analysis of the indicated p53 target genes by quantitative RT-PCR. Knockdown of USP42 decreasesmRNA expression ofmost p53 target genes. Knockdown of
p53was used to confirm p53-specific activation of promoters. Error bars represent the S.D. of three independent replicas.H, protein expression analysis of the
indicated p53 target genes byWestern blot. Knockdown of USP42 decreases protein expression of p53 target genes. Knockdown of p53 was used to confirm
p53-specific activation. CTL, control; ActD, actinomycin D; rel., relative.
FIGURE 4.USP42 knockdown increases endogenous H2B ubiquitylation specifically on the start and early extension sites of the p21 promoter upon
its induction. A–D, chromatin immunoprecipitations showing the ubiquitylation status of H2B and H2A on the p21 gene following USP42 knockdown. H2B
ubiquitylation (ubi-H2B) increases upon p21 induction at the initiator and the first intron. This is further increased by knockdown of USP42 (A), whereas H2A
ubiquitylation (ubi-H2A) is not influenced by p21 induction or USP42 knockdown (B). The difference in ubiquitylation is not an indirect result of general histone
depositionbecauseH2B andH2A levels are not altered (C andD). Error bars represent the S.D. of three independent replicas. E, expression analysis ofp21mRNA
by quantitative RT-PCR. Knockdown of USP42 decreases p21mRNAup to 38 h. F, chromatin immunoprecipitation showing the recruitment of RNA Pol II to the
p21 gene upon p53 induction. USP42 knockdown (red) increases RNA Pol II levels closer to the start site of transcription, whereas a reduced amount of RNA Pol
II is observed in thedistal part of thegene relative to control (blue). Error bars represent the S.D. of three independent replicas.ActD, actinomycinD;CTL, control;
rel., relative; p53BS, p53 binding site.
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Fig. 4, the effect of USP42 is specific to H2B at the transcrip-
tional start site (correlating with the site of USP42 binding to
the promoter) rather thanmore globally affecting histone ubiq-
uitylation. This correlates with our observation that USP42
depletion has only amodest but reproducible impact on overall
ubiquitylated H2B levels (Fig. 2H). We suggest that this may
reflect the selectivity of USP42 function in only controlling
ubiquitylation, and thereby transcription, of a subset of pro-
moters and the fact that promoters only constitute a very small
part of the genome.HowUSP42 gets recruited to the promoters
is not yet understood, although our data suggest that efficient
recruitment of USP42 depends on the binding of the transcrip-
tion factors such as p53 (Fig. 1C).
Our study identifies a role for USP42 in the regulation of
transcription and provides evidence that this may be mediated
through the control of histone ubiquitylation. A previous
proteomic analysis of the DUB interactome described an asso-
ciation of USP42 with histones, but also with a large number of
other proteins, including other DUBs (30). Although we can
identify an effect of USP42 on histone H2B ubiquitylation, it is
clear that the biological outcome of USP42 activity may also
reflect the interaction with many other proteins. Although
ubiquitylation of histones is an important mechanism to regu-
late transcription, the exact outcome of the regulation or mis-
regulation of histone ubiquitylation is complex, making the
effect of USP42 activity difficult to predict. This activity of
USP42 acts in concertwith our previously described function in
the transient regulation of p53 stability, and we believe these to
be independent functions of USP42. HowUSP42 is recruited to
the transcriptional start site of p21 will require further investi-
gation, although ourwork suggests that this does not depend on
DUB activity. Possibly USP42 is a component of the transcrip-
tional machinery that is recruited in response to p53 binding to
the promoter. Our preliminary studies suggest that USP42
modulationwill have disparate effects on transcription depend-
ing on the promoter and activating signal, and future studies
will be required to define in more detail the physiological func-
tion of USP42. However, our work reveals another component
of this critical pathway for the regulation of gene expression in
mammalian cells.
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